Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease

被引:23
|
作者
Mango, Robert L. [1 ]
Matteson, Eric L. [1 ,2 ]
Crowson, Cynthia S. [1 ,2 ]
Ryu, Jay H. [3 ]
Makol, Ashima [1 ,4 ]
机构
[1] Mayo Clin Coll Med & Sci, Div Rheumatol, Rochester, MN 55905 USA
[2] Mayo Clin Coll Med & Sci, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin Coll Med & Sci, Div Pulm & Crit Care Med, Rochester, MN USA
[4] Mayo Clin, Dept Internal Med, Div Rheumatol, 200 1st St SW, Rochester, MN 55905 USA
基金
美国国家卫生研究院;
关键词
Systemic sclerosis; Interstitial lung disease; Non-specific interstitial pneumonia; Usual interstitial pneumonia; Mortality modeling; IDIOPATHIC PULMONARY-FIBROSIS; SCLERODERMA LUNG; RISK PREDICTION; STAGING SYSTEM; SURVIVAL; TRIALS; SMOKING; PLACEBO; TRENDS; COHORT;
D O I
10.1007/s00408-018-0126-6
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The gender, age, and lung physiology (GAP) model, interstitial lung diseases-GAP (ILD-GAP) model, and the smoking history, age, and diffusion capacity of the lung (SADL) model were compared using a systemic sclerosis-ILD (SSc-ILD) cohort to evaluate which best determined prognosis. The models were applied to a cohort of 179 patients with SSc seen at a tertiary care center within 1 year of ILD diagnosis. Demographics, clinical characteristics, and mortality were recorded. The performance of the models was assessed using standardized mortality ratios (SMR) of observed versus predicted outcomes for calibration and concordance (c)-statistics for discrimination. SSc-ILD patients with usual interstitial pneumonia (31, 17%) had a higher mortality than those with non-specific interstitial pneumonia (147, 83%) (hazard ratio 2.27; 95%CI 1.03-4.97). All 3 models had comparable discrimination (c = 0.72, 0.72, and 0.71, respectively). Regarding calibration, the ILD-GAP model underestimated mortality (SMR 1.50; 95%CI 1.05-2.14). Calibration was acceptable for SADL (SMR 1.00; 95%CI 0.70-1.44) and GAP (SMR 0.90; 95%CI 0.63-1.29). The SADL model underestimated mortality in Stage I ILD. The ILD-GAP model underestimated mortality, and the SADL model underestimated mortality in certain subgroups. However, the GAP model performed well in this cohort, providing the best prognostic information for SSc-ILD.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 50 条
  • [21] Nailfold Videocapillaroscopy Changes Are Associated With the Presence and Severity of Systemic Sclerosis-Related Interstitial Lung Disease
    Caetano, Joana
    Paula, Filipe S.
    Amaral, Marta
    Oliveira, Susana
    Alves, Jose D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (03) : E12 - E15
  • [22] The Four Corners Sign A Specific Imaging Feature in Differentiating Systemic Sclerosis-related Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis
    Walkoff, Lara
    White, Darin B.
    Chung, Jonathan H.
    Asante, Dennis
    Cox, Christian W.
    JOURNAL OF THORACIC IMAGING, 2018, 33 (03) : 197 - 203
  • [23] Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
    Moore, Owen A.
    Goh, Nicole
    Corte, Tamera
    Rouse, Hannah
    Hennessy, Oliver
    Thakkar, Vivek
    Byron, Jillian
    Sahhar, Joanne
    Roddy, Janet
    Gabbay, Eli
    Youssef, Peter
    Nash, Peter
    Zochling, Jane
    Proudman, Susanna M.
    Stevens, Wendy
    Nikpour, Mandana
    RHEUMATOLOGY, 2013, 52 (01) : 155 - 160
  • [24] Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis
    Ariani, Alarico
    Silva, Mario
    Seletti, Valeria
    Bravi, Elena
    Saracco, Marta
    Parisi, Simone
    De Gennaro, Fabio
    Idolazzi, Luca
    Caramaschi, Paola
    Benini, Camilla
    Bodini, Flavio Cesare
    Scire, Carlo Alberto
    Carrara, Greta
    Lumetti, Federica
    Alfieri, Veronica
    Bonati, Elisa
    Lucchini, Gianluca
    Aiello, Marina
    Santilli, Daniele
    Mozzani, Flavio
    Imberti, Davide
    Michieletti, Emanuele
    Arrigoni, Eugenio
    Delsante, Giovanni
    Pellerito, Raffaele
    Fusaro, Enrico
    Chetta, Alfredo
    Sverzellati, Nicola
    RHEUMATOLOGY, 2017, 56 (06) : 922 - 927
  • [25] KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease
    Salazar, Gloria A.
    Kuwana, Masataka
    Wu, Minghua
    Estrada-Y-Martin, Rosa M.
    Ying, Jun
    Charles, Julio
    Mayes, Maureen D.
    Assassi, Shervin
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1153 - 1158
  • [26] Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Roth, Michael D.
    Clements, Philip J.
    Khanna, Dinesh
    Furst, Daniel E.
    Mayes, Maureen
    Charles, Julio
    Tseng, Chi-Hong
    Elashoff, Robert M.
    Assassi, Shervin
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [27] PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AFTER THE LUNG TRANSPLANTATION: A RETROSPECTIVE STUDY
    Nakayama, Y.
    Nakashima, R.
    Handa, T.
    Ohsumi, A.
    Yamada, Y.
    Nakajima, D.
    Yutaka, Y.
    Tanaka, S.
    Hamada, S.
    Ikezoe, K.
    Tanizawa, K.
    Shirakashi, M.
    Hiwa, R.
    Tsuji, H.
    Kitagori, K.
    Akizuki, S.
    Yoshifuji, H.
    Date, H.
    Morinobu, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 160 - 161
  • [28] Interstitial lung disease in systemic sclerosis
    Bussone, Guillaume
    Mouthon, Luc
    AUTOIMMUNITY REVIEWS, 2011, 10 (05) : 248 - 255
  • [29] Interstitial Lung Disease in Systemic Sclerosis
    Wells, Athol U.
    Margaritopoulos, George A.
    Antoniou, Katerina M.
    Denton, Chris
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (02) : 213 - 221
  • [30] Therapeutic effects of thalidomide on patients with systemic sclerosis-associated interstitial lung disease
    Pan, Jie
    Dong, Fei
    Ma, Li
    Zhao, Cheng
    Qin, Fang
    Wen, Jing
    Wei, Wanling
    Lei, Ling
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2023, 8 (03) : 231 - 240